Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Total Non-Current Liabilities (2020 - 2025)

Historic Total Non-Current Liabilities for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $197.4 million.

  • GeneDx Holdings' Total Non-Current Liabilities rose 345.23% to $197.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $197.4 million, marking a year-over-year increase of 345.23%. This contributed to the annual value of $168.6 million for FY2024, which is 419.88% down from last year.
  • Latest data reveals that GeneDx Holdings reported Total Non-Current Liabilities of $197.4 million as of Q3 2025, which was up 345.23% from $183.5 million recorded in Q2 2025.
  • In the past 5 years, GeneDx Holdings' Total Non-Current Liabilities registered a high of $385.7 million during Q2 2021, and its lowest value of $140.4 million during Q3 2023.
  • Over the past 5 years, GeneDx Holdings' median Total Non-Current Liabilities value was $182.4 million (recorded in 2025), while the average stood at $206.7 million.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 13698.17% in 2021, then plummeted by 5495.32% in 2022.
  • Quarter analysis of 5 years shows GeneDx Holdings' Total Non-Current Liabilities stood at $144.1 million in 2021, then soared by 47.98% to $213.2 million in 2022, then dropped by 17.45% to $176.0 million in 2023, then fell by 4.2% to $168.6 million in 2024, then rose by 17.06% to $197.4 million in 2025.
  • Its last three reported values are $197.4 million in Q3 2025, $183.5 million for Q2 2025, and $182.4 million during Q1 2025.